# Dollar General Corp: financial statements, quarterly

DG · NYSE · CIK 29534 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 29

Pages: [Overview](/companies/dg.md) · [Financials](/companies/dg/financials.md) · [Filings](/companies/dg/filings.md) · [Insiders](/companies/dg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-11-03) | Q4 FY2023 (2024-02-02) | Q1 FY2024 (2024-05-03) | Q2 FY2024 (2024-08-02) | Q3 FY2024 (2024-11-01) | Q4 FY2024 (2025-01-31) | Q1 FY2025 (2025-05-02) | Q2 FY2025 (2025-08-01) | Q3 FY2025 (2025-10-31) | Q4 FY2025 (2026-01-30) | Q1 FY2026 (2026-05-01) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [9.7](/filings/0001558370-24-016024.md) | [9.9 d](/filings/0001104659-26-032325.md) | [9.9](/filings/0001558370-25-008354.md) | [10.2](/filings/0001558370-25-011786.md) | [10.2](/filings/0001104659-25-118289.md) | [10.3 d](/filings/0001104659-26-032325.md) | [10.4](/filings/0001104659-26-069205.md) | [10.7](/filings/0001104659-26-101932.md) | [10.6](/filings/0001104659-25-118289.md) | [10.9 d](/filings/0001104659-26-032325.md) | [10.8](/filings/0001104659-26-069205.md) | [11.3](/filings/0001104659-26-101932.md) |
| Cost of revenue | $bn | [6.9](/filings/0001558370-24-016024.md) | [7.0 d](/filings/0001104659-26-032325.md) | [6.9](/filings/0001558370-25-008354.md) | [7.2](/filings/0001558370-25-011786.md) | [7.2](/filings/0001104659-25-118289.md) | [7.3 d](/filings/0001104659-26-032325.md) | [7.2](/filings/0001104659-26-069205.md) | [7.4](/filings/0001104659-26-101932.md) | [7.5](/filings/0001104659-25-118289.md) | [7.6 d](/filings/0001104659-26-032325.md) | [7.4](/filings/0001104659-26-069205.md) | [7.6](/filings/0001104659-26-101932.md) |
| Gross profit | $bn | [2.8](/filings/0001558370-24-016024.md) | [2.9 d](/filings/0001104659-26-032325.md) | [3.0](/filings/0001558370-25-008354.md) | [3.1](/filings/0001558370-25-011786.md) | [2.9](/filings/0001104659-25-118289.md) | [3.0 d](/filings/0001104659-26-032325.md) | [3.2](/filings/0001104659-26-069205.md) | [3.4](/filings/0001104659-26-101932.md) | [3.2](/filings/0001104659-25-118289.md) | [3.3 d](/filings/0001104659-26-032325.md) | [3.4](/filings/0001104659-26-069205.md) | [3.7](/filings/0001104659-26-101932.md) |
| Selling, general and administrative | $bn | [2.4](/filings/0001558370-24-016024.md) | [2.3 d](/filings/0001104659-26-032325.md) | [2.4](/filings/0001558370-25-008354.md) | [2.5](/filings/0001558370-25-011786.md) | [2.6](/filings/0001104659-25-118289.md) | [2.7 d](/filings/0001104659-26-032325.md) | [2.7](/filings/0001104659-26-069205.md) | [2.8](/filings/0001104659-26-101932.md) | [2.8](/filings/0001104659-25-118289.md) | [2.7 d](/filings/0001104659-26-032325.md) | [2.8](/filings/0001104659-26-069205.md) | [2.9](/filings/0001104659-26-101932.md) |
| Operating income | $bn | [0.4](/filings/0001558370-24-016024.md) | [0.6 d](/filings/0001104659-26-032325.md) | [0.5](/filings/0001558370-25-008354.md) | [0.5](/filings/0001558370-25-011786.md) | [0.3](/filings/0001104659-25-118289.md) | [0.3 d](/filings/0001104659-26-032325.md) | [0.6](/filings/0001104659-26-069205.md) | [0.6](/filings/0001104659-26-101932.md) | [0.4](/filings/0001104659-25-118289.md) | [0.6 d](/filings/0001104659-26-032325.md) | [0.6](/filings/0001104659-26-069205.md) | [0.8](/filings/0001104659-26-101932.md) |
| Interest expense | $bn | [0.1](/filings/0001558370-23-019576.md) | [0.1 d](/filings/0001558370-24-003813.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [0.1](/filings/0001558370-24-016024.md) | [0.1 d](/filings/0001104659-26-032325.md) | [0.1](/filings/0001558370-25-008354.md) | [0.1](/filings/0001558370-25-011786.md) | [0.1](/filings/0001104659-25-118289.md) | [0.0 d](/filings/0001104659-26-032325.md) | [0.1](/filings/0001104659-26-069205.md) | [0.1](/filings/0001104659-26-101932.md) | [0.1](/filings/0001104659-25-118289.md) | [0.1 d](/filings/0001104659-26-032325.md) | [0.1](/filings/0001104659-26-069205.md) | [0.2](/filings/0001104659-26-101932.md) |
| Net income | $bn | [0.3](/filings/0001558370-24-016024.md) | [0.4 d](/filings/0001104659-26-032325.md) | [0.4](/filings/0001558370-25-008354.md) | [0.4](/filings/0001558370-25-011786.md) | [0.2](/filings/0001104659-25-118289.md) | [0.2 d](/filings/0001104659-26-032325.md) | [0.4](/filings/0001104659-26-069205.md) | [0.4](/filings/0001104659-26-101932.md) | [0.3](/filings/0001104659-25-118289.md) | [0.4 d](/filings/0001104659-26-032325.md) | [0.4](/filings/0001104659-26-069205.md) | [0.6](/filings/0001104659-26-101932.md) |
| Diluted EPS | $ per share | [1.26](/filings/0001558370-24-016024.md) | not reported | [1.65](/filings/0001558370-25-008354.md) | [1.70](/filings/0001558370-25-011786.md) | [0.89](/filings/0001104659-25-118289.md) | not reported | [1.78](/filings/0001104659-26-069205.md) | [1.86](/filings/0001104659-26-101932.md) | [1.28](/filings/0001104659-25-118289.md) | not reported | [2.00](/filings/0001104659-26-069205.md) | [2.48](/filings/0001104659-26-101932.md) |
| Basic EPS | $ per share | [1.26](/filings/0001558370-24-016024.md) | not reported | [1.65](/filings/0001558370-25-008354.md) | [1.70](/filings/0001558370-25-011786.md) | [0.89](/filings/0001104659-25-118289.md) | not reported | [1.78](/filings/0001104659-26-069205.md) | [1.87](/filings/0001104659-26-101932.md) | [1.28](/filings/0001104659-25-118289.md) | not reported | [2.02](/filings/0001104659-26-069205.md) | [2.49](/filings/0001104659-26-101932.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-11-03) | FY2023 (2024-02-02) | Q1 FY2024 (2024-05-03) | Q2 FY2024 (2024-08-02) | Q3 FY2024 (2024-11-01) | FY2024 (2025-01-31) | Q1 FY2025 (2025-05-02) | Q2 FY2025 (2025-08-01) | Q3 FY2025 (2025-10-31) | FY2025 (2026-01-30) | Q1 FY2026 (2026-05-01) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001558370-23-019576.md) | [0.5](/filings/0001558370-25-003413.md) | [0.7](/filings/0001558370-24-008742.md) | [1.2](/filings/0001558370-24-012525.md) | [0.5](/filings/0001558370-24-016024.md) | [0.9](/filings/0001104659-26-032325.md) | [0.9](/filings/0001558370-25-008354.md) | [1.3](/filings/0001558370-25-011786.md) | [1.2](/filings/0001104659-25-118289.md) | [1.1](/filings/0001104659-26-101932.md) | [1.4](/filings/0001104659-26-069205.md) | [1.6](/filings/0001104659-26-101932.md) |
| Current assets | $bn | [8.3](/filings/0001558370-23-019576.md) | [8.0](/filings/0001558370-25-003413.md) | [8.1](/filings/0001558370-24-008742.md) | [8.7](/filings/0001558370-24-012525.md) | [8.2](/filings/0001558370-24-016024.md) | [8.2](/filings/0001104659-26-032325.md) | [7.9](/filings/0001558370-25-008354.md) | [8.4](/filings/0001558370-25-011786.md) | [8.4](/filings/0001104659-25-118289.md) | [7.9](/filings/0001104659-26-101932.md) | [8.5](/filings/0001104659-26-069205.md) | [8.8](/filings/0001104659-26-101932.md) |
| Total assets | $bn | [30.6](/filings/0001558370-23-019576.md) | [30.8](/filings/0001558370-25-003413.md) | [31.0](/filings/0001558370-24-008742.md) | [31.8](/filings/0001558370-24-012525.md) | [31.5](/filings/0001558370-24-016024.md) | [31.1](/filings/0001104659-26-032325.md) | [31.0](/filings/0001558370-25-008354.md) | [31.7](/filings/0001558370-25-011786.md) | [31.7](/filings/0001104659-25-118289.md) | [31.0](/filings/0001104659-26-101932.md) | [31.7](/filings/0001104659-26-069205.md) | [32.2](/filings/0001104659-26-101932.md) |
| Current liabilities | $bn | [6.8](/filings/0001558370-23-019576.md) | [6.7](/filings/0001558370-25-003413.md) | [6.6](/filings/0001558370-24-008742.md) | [7.1](/filings/0001558370-24-012525.md) | [7.1](/filings/0001558370-24-016024.md) | [6.9](/filings/0001104659-26-032325.md) | [6.4](/filings/0001558370-25-008354.md) | [6.7](/filings/0001558370-25-011786.md) | [7.2](/filings/0001104659-25-118289.md) | [7.0](/filings/0001104659-26-101932.md) | [7.2](/filings/0001104659-26-069205.md) | [7.3](/filings/0001104659-26-101932.md) |
| Total liabilities | $bn | not reported | not reported | not reported | not reported | not reported | [23.7](/filings/0001104659-26-032325.md) | [23.3](/filings/0001558370-25-008354.md) | [23.6](/filings/0001558370-25-011786.md) | [23.5](/filings/0001104659-25-118289.md) | [22.5](/filings/0001104659-26-101932.md) | [22.9](/filings/0001104659-26-069205.md) | [22.9](/filings/0001104659-26-101932.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.8](/filings/0001558370-23-019576.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [6.5](/filings/0001558370-24-016024.md) | [6.7](/filings/0001104659-26-032325.md) | [7.0](/filings/0001558370-25-011786.md) | [7.3](/filings/0001104659-25-118289.md) | [7.3](/filings/0001104659-25-118289.md) | [7.4](/filings/0001104659-26-101932.md) | [7.7](/filings/0001104659-26-101932.md) | [8.0](/filings/0001104659-26-101932.md) | [8.2](/filings/0001104659-25-118289.md) | [8.5](/filings/0001104659-26-101932.md) | [8.8](/filings/0001104659-26-101932.md) | [9.3](/filings/0001104659-26-101932.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-11-03) | Q4 FY2023 (2024-02-02) | Q1 FY2024 (2024-05-03) | Q2 FY2024 (2024-08-02) | Q3 FY2024 (2024-11-01) | Q4 FY2024 (2025-01-31) | Q1 FY2025 (2025-05-02) | Q2 FY2025 (2025-08-01) | Q3 FY2025 (2025-10-31) | Q4 FY2025 (2026-01-30) | Q1 FY2026 (2026-05-01) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [715 d](/filings/0001558370-24-016024.md) | [950 d](/filings/0001104659-26-032325.md) | [664](/filings/0001558370-25-008354.md) | [989 d](/filings/0001558370-25-011786.md) | [542 d](/filings/0001104659-25-118289.md) | [801 d](/filings/0001104659-26-032325.md) | [847](/filings/0001104659-26-069205.md) | [968 d](/filings/0001104659-26-101932.md) | [1,004 d](/filings/0001104659-25-118289.md) | [816 d](/filings/0001104659-26-032325.md) | [716](/filings/0001104659-26-069205.md) | [781 d](/filings/0001104659-26-101932.md) |
| Capital expenditure | $m | [473 d](/filings/0001558370-24-016024.md) | [460 d](/filings/0001104659-26-032325.md) | [342](/filings/0001558370-25-008354.md) | [354 d](/filings/0001558370-25-011786.md) | [341 d](/filings/0001104659-25-118289.md) | [273 d](/filings/0001104659-26-032325.md) | [291](/filings/0001104659-26-069205.md) | [403 d](/filings/0001104659-26-101932.md) | [314 d](/filings/0001104659-25-118289.md) | [234 d](/filings/0001104659-26-032325.md) | [352](/filings/0001104659-26-069205.md) | [407 d](/filings/0001104659-26-101932.md) |
| Dividends paid | $m | [129 d](/filings/0001558370-24-016024.md) | [130 d](/filings/0001104659-26-032325.md) | [130](/filings/0001558370-25-008354.md) | [130 d](/filings/0001558370-25-011786.md) | [130 d](/filings/0001104659-25-118289.md) | [130 d](/filings/0001104659-26-032325.md) | [130](/filings/0001104659-26-069205.md) | [130 d](/filings/0001104659-26-101932.md) | [130 d](/filings/0001104659-25-118289.md) | [130 d](/filings/0001104659-26-032325.md) | [130](/filings/0001104659-26-069205.md) | [130 d](/filings/0001104659-26-101932.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-28) | Q1 FY2023 (2023-05-05) | Q2 FY2023 (2023-08-04) | Q3 FY2023 (2023-11-03) | Q1 FY2024 (2024-05-03) | Q2 FY2024 (2024-08-02) | Q3 FY2024 (2024-11-01) | Q1 FY2025 (2025-05-02) | Q2 FY2025 (2025-08-01) | Q3 FY2025 (2025-10-31) | Q1 FY2026 (2026-05-01) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [226](/filings/0001558370-23-019576.md) | [220](/filings/0001558370-24-008742.md) | [220](/filings/0001558370-24-012525.md) | [220](/filings/0001558370-24-016024.md) | [220](/filings/0001558370-25-008354.md) | [220](/filings/0001558370-25-011786.md) | [220](/filings/0001104659-25-118289.md) | [220](/filings/0001104659-26-069205.md) | [221](/filings/0001104659-26-101932.md) | [221](/filings/0001104659-25-118289.md) | [222](/filings/0001104659-26-069205.md) | [222](/filings/0001104659-26-101932.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 220,616,790 at 2026-08-25, from the cover of the [10-Q filed 2026-08-27](/filings/0001104659-26-101932.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.